✦ LIBER ✦

Biomarkers in the development of anti-angiogenic therapies for ovarian cancer

✍ Scribed by Fharat A. Raja; Jane M. Hook; Jonathan A. Ledermann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overview of anti-angiogenic agents in de

✍ Robert A. Burger 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 343 KB

Surrogate biomarkers for anti-angiogenic

✍ Christopher G. Willett; Daniel G. Duda; Rakesh K. Jain 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 130 KB

Anti-angiogenic therapy in ovarian cance

✍ Robert S. Mannel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 96 KB

MiR-378 as a biomarker for response to a

✍ Chan, John K.; Kiet, Tuyen K.; Blansit, Kevin; Ramasubbaiah, Rashmi; Hilton, Joa 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Anti-angiogenic therapy in ovarian cance

✍ Antonio González Martín 📂 Article 📅 2009 🏛 Springer Milan 🌐 Spanish ⚖ 106 KB

The promise of anti-angiogenic cancer th

✍ Oehler, M K; Bicknell, R 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB